Pulmonary Nocardiosis Presenting as Exacerbation of Chronic Pulmonary Disease

Roopa Kancherla1, Ramanathan Palaniappan Ramanathan1, Bobbe Appalaraju2

  • 1Department of Pulmonology, PSG Institute of Medical Sciences and Research, Peelamedu, Coimbatore, Tamil Nadu, India.

Abstract

Insights

Pulmonary nocardiosis (PN) is a rare cause of acute exacerbation in chronic pulmonary disease (CPD). PN exacerbations present with longer symptoms and leukocytosis, requiring longer hospital stays and mechanical ventilation.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Pulmonary nocardiosis (PN) can occur in chronic pulmonary disease (CPD) without typical risk factors.
  • Clinical distinctions between bacterial exacerbations (AE-CPDb) and PN-related exacerbations (AE-CPDPN) are not well-defined.

Purpose of the Study:

  • To characterize AE-CPDPN in patients lacking traditional risk factors.
  • To compare clinical features, radiology, and outcomes of AE-CPDPN with matched AE-CPDb.

Main Methods:

  • Single-center retrospective review.
  • Case-control study design.

Main Results:

  • AE-CPDPN showed longer symptom duration and higher leukocytosis at admission.
  • AE-CPDb patients had more chronic respiratory failure, cardiac disease, and pulmonary hypertension.
  • AE-CPDPN was independently associated with mechanical ventilation and longer hospital stays, but not mortality.

Conclusions:

  • PN is a rare cause of CPD exacerbation, suggested by prolonged symptoms, leukocytosis, consolidation, and cavitation.
  • AE-CPDPN is linked to extended hospitalization and increased need for mechanical ventilation.
  • Respiratory failure in AE-CPDPN is a significant predictor of mortality.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K